Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Second Hedgehog-based research collaboration for Ontogeny

Oct. 11, 1996

New introduction for fertility hormone

Oct. 4, 1996

Novo Nordisk and Schering AG sign collaborative agreement for fertility drugs

Oct. 4, 1996

Shaman and Lipha to develop antidiabetic drugs

Oct. 4, 1996

Endocrine drugs in development at Takeda

Sep. 27, 1996

U.S. clinical trials on nonsurgical alternative to hysterectomy ahead of schedule

Sep. 27, 1996

Aldose reductase inhibitors from Dainippon

Sep. 27, 1996

Antihyperglycemic agents from Wyeth-Ayerst

Sep. 27, 1996

Takeda's pipeline of metabolic drugs

Sep. 27, 1996

Orphan drug finally approved for urea cycle disorders

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...